Your Mounjaro Arrived Warm: Here's What the Evidence Says

What the SmPC actually says about heat and tirzepatide

The Mounjaro SmPC (the official prescribing document published on the electronic Medicines Compendium) sets a storage range of 2°C to 8°C. There is a permitted period at room temperature (below 30°C), but the exact number of hours or days is specified in the leaflet inside your pen box, not here, because acting on a figure you've read online is riskier than reading the source directly. What the evidence base does confirm is that GLP-1 and GIP receptor agonist proteins are temperature-sensitive biological medicines: heat accelerates breakdown in ways that aren't visible to the naked eye. The liquid stays clear; the potency doesn't.

This matters practically. A pen that sat in a warm van for several hours during a summer delivery, or arrived at an ambient 25°C after a delayed transit, may sit within the leaflet's permitted window, or it may not. You often can't know the temperature history without a data logger. That uncertainty is exactly why the guidance on Mounjaro storage is unambiguous: when in doubt, don't inject, and contact your pharmacy.

Our clinical team at nume reviews these situations case by case. A brief message to aftercare gets you a same-day answer from a prescriber, not a chatbot.

Why a warm pen can fail silently, and why that matters for your treatment

One of the more counterintuitive things about biological medicines is that degradation rarely announces itself. The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% at 15 mg tirzepatide over 72 weeks, results that depended on participants receiving potent, correctly stored doses at every step. A compromised pen won't necessarily cause a reaction; it may simply work less well, and you might spend weeks attributing poor response to the medicine when the issue was the supply chain.

This is why tirzepatide guidance consistently distinguishes between a pen that has been kept cold and one that has been exposed to warmth, even briefly. The NHS patient page for tirzepatide notes that storage conditions must be followed as directed; the eMC SmPC is the definitive reference for the exact permitted room-temperature window.

Practically, if your Mounjaro pen arrived warm, the questions to answer are: how warm, and for how long? If the packaging was intact and the pen was slightly above fridge temperature for under an hour, that's a different situation from a pen that spent a full day in a 28°C hallway. Either way, your pharmacist is the right person to make that call, not a forum thread. If you're unsure where the boundary sits, our FAQs cover storage queries in more detail, and the contact page connects you to our prescribing team directly.

What legitimately happens during transit, and what shouldn't

Mounjaro pens are dispatched by regulated UK pharmacies in insulated, temperature-controlled packaging. At nume, every order goes out via DPD next-working-day tracked delivery, in plain packaging, once a GPhC-registered prescriber has reviewed and approved it. The cold chain is part of the clinical standard, not an optional extra.

That said, transit conditions aren't always predictable. A delayed delivery in high summer, a parcel left on a doorstep for hours, or a courier vehicle without refrigeration can all push a pen outside its ideal range. These aren't hypothetical risks: the MHRA has documented problems with illegitimate sellers whose medicines never had proper cold-chain handling to begin with. What happens when Mounjaro gets warm covers those scenarios in depth, including the signs that a pen may have been stored incorrectly before it even left a seller.

If your pen arrived at room temperature from a regulated pharmacy, the first step is to put it in the fridge door (a consistent, easy-to-remember spot) and contact the pharmacy. Don't inject until you've had a response. Most reputable dispensers will replace a pen that arrived outside the cold chain, because the alternative (a patient injecting a potentially degraded medicine) is not acceptable clinical practice. You can also raise concerns about any suspect medicine through the MHRA's Yellow Card scheme, which covers both side effects and supply concerns.

If my Mounjaro arrived not cold, what happens next

The short version: pause, refrigerate, contact your pharmacy. Don't discard the pen before speaking to someone, because your pharmacist may want to understand the packaging conditions before deciding on a replacement. Keep the outer box and any temperature indicator strips that came with it, and if you want a full breakdown of what to check and how to report the issue, our guide on what to do when Mounjaro arrives not cold walks through every step.

If you're a patient mid-treatment and uncertain whether to delay your dose, that is a clinical decision, one for your prescriber, not a blanket rule. Missing a single weekly injection has different implications depending on where you are in your titration. Our prescribers are available seven days a week for exactly these situations; reach our aftercare team and you'll get a clinician's view, not a call-centre script.

For anyone still deciding which route to treatment is right for them, it's worth knowing that the cold-chain question is part of why the clinical infrastructure around the prescription matters. A cheap pen from an unverified source has often never been temperature-controlled at all. You can read more about what to look for in a regulated UK service on our about us page, and check any online pharmacy on the GPhC register at pharmacyregulation.org. The cost question is real too, our Mounjaro price comparison explains what a legitimate private prescription actually includes, cold chain and all. Questions about technique are equally common at this stage, and if you're wondering whether injecting Mounjaro in the arm is a suitable option for you, that page covers everything you need to know. When you're ready, check your eligibility with our prescribing team.